Kendle International Overview

  • Year Founded
  • 1981

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3,105

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 4

  • Investments
  • 5

Kendle International General Information

Description

Provider of Phase I-IV global clinical development services to the biopharmaceutical industry. The company offers regulatory and consulting services at every stage of drug and device development, as well as designs clinical programs and clinical trial protocols, reviews programs and provides gap analysis to assist sponsors in achieving their clinical development strategies.

Contact Information

Website
www.kendle.com
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • 441 Vine Street
  • 500 Carew Tower
  • Cincinnati, OH 45202
  • United States
+1 (513)
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Technology Systems
Other Healthcare Services
Acquirer
Vertical(s)
TMT
Corporate Office
  • 441 Vine Street
  • 500 Carew Tower
  • Cincinnati, OH 45202
  • United States
+1 (513)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kendle International Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kendle International‘s full profile, request access.

Request a free trial

Kendle International Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of Phase I-IV global clinical development services to the biopharmaceutical industry. The company offers regula
Laboratory Services (Healthcare)
Cincinnati, OH
3,105 As of 2010

Shanghai, China

Dublin, Ireland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kendle International Competitors (21)

One of Kendle International’s 21 competitors is Medkey, a Private Equity-Backed company based in Shanghai, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Medkey Private Equity-Backed Shanghai, China
Icon (Dublin) Corporation Dublin, Ireland
IQVIA Holdings Formerly PE-Backed Durham, NC
Velocity Clinical Research Private Equity-Backed Durham, NC
ProTrials Research Corporation Los Gatos, CA
You’re viewing 5 of 21 competitors. Get the full list »

Kendle International Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kendle International Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kendle International‘s full profile, request access.

Request a free trial

Kendle International Investments & Acquisitions (5)

Kendle International’s most recent deal was a Merger/Acquisition with DecisionLine Clinical Research for . The deal was made on 02-Jun-2008.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
DecisionLine Clinical Research 02-Jun-2008 Merger/Acquisition Laboratory Services (Healthcare)
Charles River Labs International (Phase II-IV Clinical Service Business) 16-Aug-2006 Merger/Acquisition Drug Discovery
Kendle Regulatory Affairs 28-Feb-2001 Merger/Acquisition Consulting Services (B2B)
Digineer 01-Jan-1999 Corporate Consulting Services (B2B)
Acer/Excel 12-Feb-1998 Merger/Acquisition Laboratory Services (Healthcare)
To view Kendle International’s complete investments and acquisitions history, request access »

Kendle International Exits (1)

Kendle International’s most recent exit was on 01-Jan-1999 from Digineer. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Digineer 01-Jan-1999 Completed
To view Kendle International’s complete exits history, request access »

Kendle International FAQs

  • When was Kendle International founded?

    Kendle International was founded in 1981.

  • Where is Kendle International headquartered?

    Kendle International is headquartered in Cincinnati, OH.

  • What is the size of Kendle International?

    Kendle International has 3,105 total employees.

  • What industry is Kendle International in?

    Kendle International’s primary industry is Laboratory Services (Healthcare).

  • Is Kendle International a private or public company?

    Kendle International is a Private company.

  • What is the current valuation of Kendle International?

    The current valuation of Kendle International is .

  • What is Kendle International’s current revenue?

    The current revenue for Kendle International is .

  • How much funding has Kendle International raised over time?

    Kendle International has raised $267M.

  • Who are Kendle International’s investors?

    Ridgemont Equity Partners has invested in Kendle International.

  • Who are Kendle International’s competitors?

    Medkey, Icon (Dublin), IQVIA Holdings, Velocity Clinical Research, and ProTrials Research are some of the 21 competitors of Kendle International.

  • When was Kendle International acquired?

    Kendle International was acquired on 27-May-2011.

  • Who acquired Kendle International?

    Kendle International was acquired by INC Research.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process